Tech Company Financing Transactions
ProteinSimple Funding Round
On 5/24/2011, ProteinSimple raised $13 million in Series F funding from private investors.
Transaction Overview
Company Name
Announced On
5/24/2011
Transaction Type
Venture Equity
Amount
$13,000,866
Round
Series F
Investors
Proceeds Purpose
The company issued approximately $9 million of the total amount to purchase all of the outstanding shares of Brightwell Technologies. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3040 Oakmead Village Dr.
Santa Clara, CA 95051
USA
Santa Clara, CA 95051
USA
Phone
Website
Email Address
Overview
ProteinSimple is a private life sciences company focused on defining the future of protein analysis. Our company develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tim Harkness
Chief Financial Officer
Jason Novi
VP - Bus. Development
Trent Basarsky
VP - Product Management
Robert Gavin
VP - Sales
Terry Salyer
Browse more venture capital transactions:
Prev: 5/24/2011: Radius Health venture capital transaction
Next: 5/24/2011: Lark Health venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs